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ABSTRACT 
 The incidence of melanoma is increasing rapidly in the United States. Sentinel lymph 
node biopsy is an important diagnostic tool in the treatment and staging of melanoma. However, 
many patients with melanoma will have had lymph node surgery for previous melanoma or 
breast cancer. We set out to examine alterations in drainage patterns in patients with previous 
axillary dissection for breast cancer. We reviewed four patients with truncal and/or extremity 
melanomas and examined their lymphoscintigraphy and drainage patterns. Three patients with 
truncal melanoma mapped to cervical lymph nodes and a fourth patient with an arm melanoma 
mapped to her previously dissected axilla. Sentinel lymph node mapping is still an important 
adjunct in patients with melanoma despite previous axillary dissection. 
 
INTRODUCTION 
 Cutaneous melanoma, a malignancy of melanocytes, has been rapidly increasing in 
incidence over the past 30 years (1). In 2010, there was an estimated 68,000 new cases of 
melanoma and nearly 9000 melanoma-associated deaths (1).  The staging, prognosis, and 
treatment algorithms of melanoma depend on the Breslow thickness, mitoses, and the presence 
or absence of regional and/or distant metastases (2).  Melanoma preferentially spreads via the 
lymphatics, and metastases typically progress through afferent lymphatic channels to sentinel 
nodes before presenting in non-sentinel lymph node sites. The presence of malignancy in 
regional lymph nodes carries a high prognostic significance, lowering the 5-year survival rate to 
50% (3). Therefore, SLNB is of paramount importance in the initial workup and subsequent 
management of cutaneous melanoma. 
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 We report 4 patients who presented with melanoma of either the upper limb or upper 
posterior trunk; each of the patients had a history of breast cancer treated via surgical resection, 
including axillary lymph node dissection. For melanomas of the upper limb and posterior trunk, 
the site of sentinel lymph nodes is the ipsilateral axilla 99% and 93% of the time, respectively 
(5). If the axillary nodal basin is surgically removed, as in the case of the 4 reported patients, the 
lymphatic drainage may follow an alternate pathway with the sentinel nodes located in different 
nodal basins. There is very little literature regarding sentinel lymph node localization in those 
patients whose lymphatic drainage is significantly altered. 
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METHODS 
 This is a retrospective case review of an IRB-approved melanoma data base. Upon 
review, 4 patients were identified who had a history of a partial mastectomy with axillary node 
dissection for the treatment of breast carcinoma and later presented with a cutaneous melanoma 
in a location that classically drains to the axillary node basin. Each patient underwent 
preoperatively lymphoscintigraphy to identify sentinel lymph nodes.   
 
RESULTS  
Patient No. 1 
 A 36-year-old female underwent bilateral mastectomies, including right axillary node 
dissection in 1994 for right-sided breast carcinoma and. In April 2006, she presented with a 0.9 
millimeter melanoma on her right forearm. After excision with 1cm margins, SLNB was 
recommended; lymphoscintigraphy revealed a right axillary sentinel lymph node. Three sentinel 
lymph nodes were identified just posterior to the thoracodorsal nerve. The final routine and 
immunohistochemical stains of the lymph nodes were negative for melanoma.    
Patient No. 2 
 A 38-year-old female underwent right modified radical mastectomy in 1981 for right-side 
breast cancer. In November 2006, she presented with a pigmented lesion on her right upper back. 
Biopsy was consistent with a malignant melanoma 0.5 millimeters in depth, Clark level IV. It 
was decided to proceed with a wide local excision and SLNB. Preoperative lymphoscintigraphy 
revealed a right supraclavicular lymph node. She underwent wide local excision of her 
melanoma and removal of 2 cervical lymph nodes which were negative for melanoma. 
Patient No. 3 
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 The third patient is a 79-year old female who previously underwent a left axillary 
dissection for a left back melanoma. She also underwent a right partial mastectomy and axillary 
lymph node dissection in 1999 for breast cancer. She presented in 2011 with a 3.7 mm thick, 
nodular melanoma with ulceration on her right upper back. The patient was advised to proceed 
with a wide local excision of the melanoma and SLNB. Preoperative lymphoscintigraphy 
revealed a right supraclavicular sentinel lymph node.  The patient underwent wide excision and 
dissection of 2 cervical lymph nodes. The lymph nodes were negative for metastatic melanoma. 
Patient No. 4 
 A 73-year-old female treated in 1994 for right breast cancer with a partial mastectomy 
and axillary lymph node dissection. In November 2009, she presented with a lesion on her right 
posterior shoulder with biopsy consistent with a 0.7 mm melanoma. Re-excision of the lesion 
revealed an additional 4 mm of melanoma; SLNB was recommended. Lymphoscintigraphy 
revealed a supraclavicular sentinel lymph node. Subsequently, the patient underwent excision of 
two right-sided cervical lymph nodes which, on subsequent pathology were deemed to be free of 
melanoma.  
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DISCUSSION 
 By definition, a sentinel lymph node is any lymph node that receives lymphatic drainage 
directly from the primary tumor. Within a particular nodal basin, a sentinel node is the first node 
to receive lymphatic drainage; therefore, the histology of the sentinel node if felt to be 
representative of all other nodes in the basin (6). Historically, the only way to successfully 
identify sentinel nodes was to perform a complete lymph node dissection and study the 
pathology of each individual node within that basin. With the advent of cutaneous 
lymphoscintigraphy in 1977, Fee and colleagues began to characterize lymphatic drainage 
patterns of melanoma (7).  In 1993, Alex and Krag introduced the concept of performing 
lymphoscintigraphy with teachnetium-99m sulfur colloid followed by intraoperative use of a 
handheld gamma probe for a more precise localization of sentinel nodes (8). Currently, pre-
operative lymphoscintigraphy, intraoperative intradermal injection of blue-dye and use of the 
gamma probe are all used in conjunction to accurately identify sentinel nodes.  
 One of the most important prognostic factors for melanoma is the presence and/or 
absence of malignancy in the regional lymph nodes draining the primary tumor (4).  For this 
reason, the use of lymphoscintigraphy and sentinel node biopsy (SNB) is routine practice in the 
workup of patients presenting with a primary cutaneous melanoma. SNB is recommended for all 
Stage Ia melanomas with adverse prognostic features (thickness > 0.75 mm, lymphovascular 
invasion, positive deep margins, ulceration, and mitoses), Stage IB, Stage II, and in-transit 
melanomas.  
 However, there is no clear consensus on how to investigate lymphatic metastases in those 
patients with melanoma whose regional lymphatic basins have been surgically altered. There is 
no recommendation to proceed with SNB when the lymph node basin that classically contains 
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the sentinel node has already been removed.  In fact, some advocate that if lymphatic channels 
have been disrupted by previous surgery, lymphoscintigraphy is not indicated because nodes 
may be falsely identified as being sentinel (9). However, with the technological advancements in 
lymphatic mapping, it has become relatively common to detect sentinel nodes in nodal basins not 
previous thought to receive lymphatic drainage directly from the tumor.  Studies report 
discordance between the drainage patterns identified via lymphoscintigraphy and the predicted 
pattern in 32%-62% of cases of truncal melanoma (2). Therefore, removing the lymphatic basin 
typically containing the sentinel node does not preclude the existence of sentinel nodes in other 
atypical nodal basins.  Moreover, when entire lymph node basins have been removed, the 
lymphatic drainage patterns will alter their course to follow new and unexpected routes. In 2004, 
Sood et al reported four patients with a history of breast carcinoma who underwent lumpectomy 
and axillary lymph node dissection and subsequently developed recurrence in the same breast 
(6). Each of the patients underwent lymphoscintigraphy in the workup of their cancer recurrence. 
The results of lymphoscintigraphy showed altered lymphatic drainage patterns of the residual 
breast tissue and different sentinel node locations (6). 
 Our experience yielded similar results, suggesting that the removal of classically located 
sentinel lymph node basins does not preclude the existence of additional sentinel nodes. Results 
from three out of four patients demonstrate that although lymphatic drainage of the trunk is often 
to the axillary node basin, supraclavicular and cervical node basins may contain sentinel nodes 
which are potential sites of metastatic disease. The lymphoscintigraphy results of Patient 1 show 
that a sentinel node may even exist in what was previously felt to be completely dissected lymph 
node basin. Given that lymphoscintigraphy is minimally invasive and relatively inexpensive, it is 
a cost effective means to identify sentinel nodes and allow for an accurate biopsy. Based on our 
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experience, lymphoscintigraphy and sentinel lymph node biopsy should be performed even if 
traditional sentinel nodal basins have been removed. 
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Operative 
Findings 
Pathology 
  Primary 
Site 
Thickness Ulceration T 
Stage 
   
1 Bilateral 
MRM  
Right 
Forearm 
0.9 mm N T1b Right Axillary Node 3 lymph 
nodes 
identified 
with Blue 
Dye and 
Neoprobe  
Negative 
for 
malignancy 
2 Right MRM Right 
upper 
back 
0.5 mm N T1a Right Cervical Node 2 lymph 
nodes 
identified 
with Blue 
Dye and 
Neoprobe   
Negative 
for 
malignancy 
3 Left partial 
mastectomy 
& ALND 
Left 
upper 
posterior 
trunk 
3.7 mm Y T3b Right 
Supraclavicular 
Node 
2 lymph 
nodes 
identified 
with Blue 
Dye and 
Neoprobe 
Negative 
for 
malignancy 
4 Right partial 
mastectomy 
& ALND 
Right 
posterior 
shoulder 
4 mm N T4a Right 
Supraclavicular 
Node 
2 lymph 
nodes 
identified 
with 
Lymphazurin 
Blue Dye 
and 
Neoprobe 
Negative 
for 
malignancy 
MRM-modified radical mastectomy 
ALND-axillary lymph node dissection 
 
Figure Legends: 
Figure 1- right upper back melanoma; anterior image obtained 15 minutes after radiotracer 
injection shows a right supraclavicular lymph node (arrow) superior to the injection site . 
Figure 2—posterior shoulder melanoma; anterior image obtained 5 minutes subsequent to 
radiotracer injection demonstrates a right cervical sentinel lymph node (arrow) just lateral to the 
projection of the injection site. 
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